Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:12 pm Purchase | 2026-02-11 | 13G | BioRestorative Therapies, Inc. BRTX | Mitchell P. Kopin | 922,143 4.100% | 922,143 (New Position) | Filing History |
| 2026-02-17 4:09 pm Purchase | 2026-02-11 | 13G | MDJM Ltd UOKA | Mitchell P. Kopin | 548,355 9.990% | 548,355 (New Position) | Filing History |
| 2026-02-13 4:49 pm Purchase | 2025-12-31 | 13G | Silexion Therapeutics Ltd. SLXN | Mitchell P. Kopin | 325,000 9.400% | 80,229 (+32.78%) | Filing History |
| 2026-02-13 4:48 pm Purchase | 2025-12-31 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 1,478,164 9.990% | 93,754 (+6.77%) | Filing History |
| 2026-02-13 4:47 pm Purchase | 2025-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 532,254 4.990% | 532,254 (New Position) | Filing History |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 1,142,556 9.100% | 712,556 (+165.71%) | Filing History |
| 2026-02-13 4:45 pm Purchase | 2025-12-31 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 200,000 8.100% | 200,000 (New Position) | Filing History |
| 2026-02-13 4:44 pm Purchase | 2025-12-31 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 593,804 9.990% | 86,080 (+16.95%) | Filing History |
| 2026-02-13 4:43 pm Purchase | 2025-12-31 | 13G | SeaStar Medical Holding Corporation ICU | Mitchell P. Kopin | 3,980,665 9.990% | 3,670,848 (+1184.84%) | Filing History |
| 2026-02-13 4:43 pm Purchase | 2025-12-31 | 13G | GRI Bio, Inc. GRI | Mitchell P. Kopin | 1,097,858 9.990% | 1,073,662 (+4437.43%) | Filing History |
| 2026-02-13 4:41 pm Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | Mitchell P. Kopin | 4,806,174 9.990% | 4,692,200 (+4116.91%) | Filing History |
| 2026-02-13 4:39 pm Purchase | 2025-12-31 | 13G | Cemtrex, Inc. CETX | Mitchell P. Kopin | 605,011 7.300% | 522,993 (+637.66%) | Filing History |
| 2026-02-13 4:38 pm Purchase | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Mitchell P. Kopin | 91,537 4.990% | 47,142 (+106.19%) | Filing History |
| 2026-02-13 4:37 pm Purchase | 2025-12-31 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI | Mitchell P. Kopin | 475,116 9.990% | 136,864 (+40.46%) | Filing History |
| 2026-02-13 4:36 pm Purchase | 2025-12-31 | 13G | Actelis Networks, Inc. ASNS | Mitchell P. Kopin | 849,800 9.990% | 655,817 (+338.08%) | Filing History |
| 2026-02-13 4:30 pm Purchase | 2026-02-09 | 13G | Iveda Solutions, Inc. IVDA | Mitchell P. Kopin | 592,195 4.990% | 592,195 (New Position) | Filing History |
| 2026-02-04 4:21 pm Purchase | 2026-01-29 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 10,100,615 9.990% | 10,100,615 (New Position) | Filing History |
| 2026-02-02 9:16 pm Purchase | 2026-01-28 | 13G | Reliance Global Group, Inc. RELI | Mitchell P. Kopin | 942,906 4.990% | 942,906 (New Position) | Filing History |
| 2026-02-02 8:29 pm Purchase | 2026-01-27 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 71,246 4.990% | 39,893 (+127.24%) | Filing History |
| 2026-01-23 4:25 pm Purchase | 2026-01-15 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 6,002,185 8.200% | 6,002,185 (New Position) | Filing History |